Password reset request
  • Portal do Governo Brasileiro
  • Atualize sua Barra de Governo
  • Go to main content [1]
  • Go to main menu [2]
  • Enable hight contrast [3]
English Português Español
  • Sign in
    Forgot my password
> About  >
-
-
-
-
-
 
 

About ReBEC


ReBEC is publicly-owned, managed by the Oswaldo Cruz Foundation, a research organization in government and nonprofit organizations. All details of the studies reported in ReBEC are publicly available. According to resolution of ANVISA - RDC 36, of 27 June 2012 amending RDC 39/2008, all clinical phases I, II, III and IV, must show proof of registration of clinical research in the database Brazilian Registry of Clinical Trials - ReBEC, or proof of submission. For cases prior to publication of this resolution will be accepted proof of registration of the researches that have already been recorded in other primary records of the International Clinical Trials Registration Platform (ICTRP / WHO). For every record there is no cost. The required fields of ReBEC meet the minimum data set required by the International Committee of Medical Journal Editors (ICMJE) and the World Health Organization (WHO). After review and at the time of publication of the study in ReBEC website, the study receives a unique registration number. The responsibility for recording and reporting of studies is the sponsor. The test data will not be removed after they are posted. The result of a joint effort of the Ministry of Health (DECIT/MS), Institute of Communication and Information Science and Technology in Health (Icict/Fiocruz), the Pan American Health Organization (PAHO) and the Latin American and Caribbean Center on Health Sciences (Bireme), the ReBEC increases the effectiveness of efforts to disclose clinical trial studies public way, reducing publication bias. Thus, the ReBEC becomes an important source of information for patients, health professionals, researchers, companies and research centers, providing greater interaction and international integration. Institutional - Coordination Dr. Josue Laguardia
Senior Research Consultant
Dr Luiza Silva Coordinator Fundação Oswaldo Cruz
Instituto de Comunicação e Informação Científica e Tecnológica em Saúde – Icict
Av. Brasil, 4036 - Office Building Expansion - Room 807
Zip Code: 21040-361 - Rio de Janeiro, RJ - Brazil

Phone: +55(21)3882-9227
E-mail: rebec@icict.fiocruz.br
 
Approved trials

12/05/2025
Effects of Erbium Laser on Facial Rejuvenation
 
12/05/2025
Brazilian Red Propolis Gel for Oral Mucositis from Chemotherapy
 
12/04/2025
Effect of Transcranial Magnetic Stimulation (TMS) associated with speech-language pathology treatment in patients with difficulty swallowing after a stroke
 
12/04/2025
CRONOEX: how the time of day when physical exercise is performed influences brain function and blood glucose control in people with type 2 Diabetes
 
12/04/2025
Effect of Hippotherapy on biopsychomotor and functional skills in children and adolescents with Autism Spectrum Disorder: a cohort study
 
12/04/2025
Do combined non-invasive stimulation techniques affect the brain behavior of individuals with depressive symptoms? A randomized controlled trial
 
12/04/2025
Randomized split-mouth clinical trial of Home Dental Whitening with 10%, 15%, and 20% Carbamide Peroxide
 

Total de Ensaios Clínicos 17272.

Existem 8622 ensaios clínicos registrados.

Existem 4787 ensaios clínicos recrutando.

Existem 101 ensaios clínicos em análise.

Existem 5874 ensaios clínicos em rascunho.

cadastre um novo usuário

notícias

sobre

ajuda

contato

equipe

links úteis

glossário